LDL-APHERESIS REFERENCE ARTICLES BIBLIOGRAPHY

Please email us at rtd@bbmus.com to receive a copy of any of the articles listed below.

Armstrong VW, Schleef J, Thiery J, Muche R, et.al.: Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein (a): kinetic analysis of the post-treatment return to baseline levels. Eu J of Clin Inv 1989; 19: 235-240.

Jaeger BR, Meiser B, Nagel D, Uberfuhr P, et. al.: Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation. Circulation 1997; 96: 154-158.

Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, et. al.: Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments. Am J of Cardiol 1995; 75: 1124-1129.

Lane DM, McConathy WJ, Laughlin LO, Comp PC, et. al.: Selective removal of plasma low density lipoprotein with the HELP™ system: biweekly versus weekly therapy. Atherosclerosis 1995; 114: 203-211.

Lane DM, McConathy WJ, Laughlin LO, Comp PC, et. al.: Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J of Cardiol 1993; 71: 816-822.

Lees RS, Holmes NN, Stadler RW, Ibrahim SF, et. al.: Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP). J of Clin Apheresis 1996; 11: 132-137.

Mellwig KP, Baller D, Gleichmann U, Moll D, et. al.: Improvement of coronary vasodilation capacity through single LD apheresis. Atherosclerosis 1998; 139: 173-178.

Park JW, Mechthild M, Braun P: Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia. Atherosclerosis 1998; 139: 401-409.

Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, et. al.: The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J of Clin Inv 1994; 24: 724-732.

Schuff-Werner P, Schutz E, Seyde WC, Eisenhauer TH, et. al.: Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eu J of Clin Inv 1989; 19: 30-37.

Seidel D, Armstrong VW, Schuff-Werner P: The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. Eur J of Clin Invn 1991; 21: 375-383.

Seidel D: H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10 years of clinical experience. Artif Organs 1996; 20(4): 303-310.

Seidel D: The HELP™ system: an efficient and safe method of plasmatherapy in the treatment of severe hypercholesterolemia. Therapeutische Umschau 1990; 47(6): 514-519.

Thiery J, Seidel D: Safety and effectiveness of long-term LDL-apheresis in patients at high risk. Current Opin in Lipidol 1998; 9: 521-526.

Thiery J, Walli AK, Janning G, Seidel D: Low-density lipoprotein plasmaphaeresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolaemia. Eur J Pediatr 1990; 149: 716-721.